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ABSTRACT
Objective: This study aimed to show the impact of the ZOL in VCO gel (Ge-ZOL) on the extent of osteoclasts apoptosis.
Methods: The study used 27 Sprague-Dawley rats which were divided into three groups: Nine rats in the experimental group were given 40 µg of Ge-
ZOL, nine rats in the control group were given VCO emulsion gel without ZOL (Ge-), and nine rats in the normal group were not given any treatment. 
The gel was applied to the buccal mucosa using a cotton bud for 2 min at hour of 0, 4, and 8 on days 0, 1, 2, 3, and 4. The rats were sacrificed on days 
1, 3, and 5, and then, evaluated by immunohistochemical caspase-3 staining.
Result: The number of apoptotic osteoclast cells in the experimental group was significantly higher than in the control and normal groups (p<0.05). 
The number of apoptotic osteoclast cells in the experimental group on the day 1 was significantly higher than on the days 3 and 5 (p<0.001).
Conclusion: The application of Ge-ZOL to the buccal mucosa proven to improve the number of apoptotic osteoclast cells in the experimental group on 
the day 1, and this number was higher than on the days 3 and 5.
Keywords: Zoledronate bisphosphonate, Virgin coconut oil, Caspase-3, Osteoclast apoptosis.
INTRODUCTION
Orthodontic treatment aims to improve the function of mastication, 
speech, and facial appearance as well as to maintain stability after 
treatment [1]. Orthodontic treatment works on the principle of moving 
and then securing some teeth, which is called anchorage [2,3]. There 
are several methods of anchorage such as using the dentition as an 
anchorage unit, using additional extraoral anchorage such as headgear, 
using additional intraoral anchorage such as a lingual bar and a Nance 
holding arch, or using the mini-implant or mini-screw [4-10].
Besides the mechanical tools mentioned above, there are 
pharmaceutical methods that have good potential in supporting 
anchorage through the inhibition of bone resorption. Bisphosphonate 
(BP) and prostaglandin inhibitors are two types of drug that are known 
to inhibit orthodontic tooth movement [3]. BP is a drug commonly used 
to treat osteoclastic bone resorption diseases, such as osteoporosis, 
cancers that can metastasize to the bone (breast, prostate, lung, and 
kidney cancer), bone marrow cancer (multiple myeloma), and Paget’s 
disease [11]. Zoledronate (ZOL) is the newest generation of BP, 
nitrogen-containing heterocyclic imidazole BP that has a greater ability 
to inhibit bone resorption compared to other BP [11-18]. BP can bind 
hydroxyapatite crystals in a mineralized bone matrix so that the bone 
is more resistant to the osteoclast function. BP also prevents bone 
marrow from differentiating precursor cells through the inhibition of 
the mevalonate pathway of cholesterol biosynthesis and by inducing 
osteoclast apoptosis. BP works specifically on the osteoclasts, causing 
the apoptosis of the osteoclasts, thus preventing the occurrence 
of osteoclastic bone resorption and inhibiting orthodontic tooth 
movement [18-20]. Researchers have reported several experimental 
animal studies that show that a subperiosteal injection of BP can 
inhibit orthodontic tooth movement through the anti-osteoclast effect 
of BP [18-22]. It is therefore anticipated that the administration of 
Ge-ZOL in virgin coconut oil (VCO) will have the same effect as the 
subperiosteal ZOL injection. Ge-ZOL in VCO is suggested expected as a 
way of improving the function of orthodontic anchorage by promoting 
osteoclast apoptosis [18,19].
The application of orthodontic force produces an inflammatory process 
and forms a chemical mediator that stimulates osteoclast formation 
in the pressure area. The osteoclasts will then resorb the alveolar 
bone so that the tooth can move. The mechanism of orthodontic tooth 
movement thus involves the process of resorption and bone apposition 
through osteoclast apoptosis [1-3]. Apoptosis is programed cell death 
that involves the controlled dismantling of intracellular components 
while avoiding inflammation and damage to surrounding cells [21]. The 
caspases are a family of genes important for maintaining homeostasis 
through their regulation of cell death. Immunohistochemical caspase-3 
contains an antibody that can detect and bind to antigen caspase-3 in 
osteoclasts undergoing apoptosis [23].
Subperiosteal injection of BP is invasive and painful. Thus, it is 
necessary to develop BP that can be applied topically. Ge- has several 
advantages over a regular gel as it is one of the hydrophobic and 
mucoadhesive drug delivery systems that can attach and penetrate 
easily through the oral mucosa without any pain [24-26]. The Ge- used 
in this study is VCO and carboxymethyl cellulose (CMC). VCO is pure 
coconut oil, derived from fresh coconut flesh, processed without 
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Objective: Drug has the potential to support the anchorage in orthodontic treatment through the inhibition of tooth movement resulting from
 bone resorption due to the apoptosis of osteoclasts. A subperiosteal injection of zoledronate (ZOL) can increase the apoptosis of osteoclasts. 
Several researchers have reported that a subperiosteal injection of ZOL bisphosphonate (BP) (ZOL) can act against orthodontic tooth movement by 
increasing the apoptosis of osteoclast cells. However, subperiosteal injection is invasive and painful, so a gel emulsion of ZOL in virgin coconut oil (VCO) 
was used to substitute the subperiosteal injection.
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using any chemicals or heating so that the active components such 
as the vitamins and polyphenols are not damaged. More than 60% of 
the compounds within VCO consist of medium chain saturated fatty 
acids; these are lauric acid (53%) and capric acid (7%). These are 
easily absorbed by the body due to their molecular size, which is not 
too big [27]. This study aimed to determine the impact of Ge-ZOL in 
preventing osteoclastic bone resorption. This was achieved through 
the observation of the extent osteoclast apoptosis in the rat alveolar 
bone using immunohistochemical (IHK) caspase-3.
METHODS
Twenty-seven Sprague-Dawley rats were included in this study. The 
inclusion criteria were male, 3 months old, 180-200 g, derived from 
the same strain, and in good condition. The study was done under the 
supervision of a veterinarian of the Health Research and Development 
Division of the Indonesian Ministry of Health. The study was approved 
by Research Ethical Committee of the Faculty of Medicine, Universitas 
Indonesia (Approval Number: 248/UN2.F1/ETIK/2015).
Subjects were divided into three groups: Nine rats in the experimental 
group were given Ge-ZOL with VCO, nine rats in the control group 
were given Ge- with VCO, and nine rats in the normal group were not 
given any treatment. The normal group was used to show the validity 
of the control group. 25 mg gel was made fresh, consisting of 40 µg 
ZOL. The gel was applied to the buccal mucosa of the lower right first 
molar on the days 0, 1, 2, 3, and 4 at hours 0, 4, and 8 using a cotton 
bud with the circular movement for 2 min. Three rats from each group 
were sacrificed on the days 1, 3, and 5, respectively. After sacrificed, 
the specimens were cut in the sagittal direction so that the right side of 
the mandible was obtained. Preparation of the histological specimens 
and the IHK caspase-3 staining was done at the histology laboratory 
of the Faculty of Medicine, Universitas Indonesia. The specimens 
were fixated in neutral buffer formalin 10% at 4°C for 24 h, and then, 
demineralized using Rapidcal-Immuno until soft. Samples were put 
into alcohol in sequence, xylol alcohol, mixture of xylol and paraffin, 
and liquid paraffin. The specimens were then cut with microtomes in 
a transverse direction to a thickness of ±4 μm and then dyed with IHK 
caspase-3 [23].
The specimens were observed using the Olympus IX73 research 
inverted microscope with ×20 magnification, captured with an Olympus 
DP80 camera, and then the area of the medulla was measured using the 
Olympus cellSens V.1.11 program at the UI-Olympus Bioimaging Center. 
A calibration test was performed inter- and intra-observer on 20% 
of the samples by the histological experts of the Faculty of Medicine, 
Universitas Indonesia, and the researcher.
Intra- and inter-observer reliabilities were analyzed using the Bland-
Altman test. All data were analyzed using the one-way ANOVA. The 
results were considered statistically significant when p<0.05.
RESULTS
The result of the interobserver reliability test with Bland-Altman 
showed a good reliability between the researcher and the histological 
expert. The result of the intraobserver reliability test with Bland-Altman 
showed a good reliability between the first and second examination 
results done by researcher with interval 1 week.
The results of the one-way ANOVA test showed that there were 
significant differences in the extent of osteoclasts apoptosis between 
the groups (p<0.001). Based on the post hoc Bonferroni test, there 
were significant differences between the experimental and the control 
groups on the day 1 and between the experimental and the normal 
groups on the day 1 (p<0.05) (Fig. 1).
Table 1 shows that the number of apoptotic osteoclasts cells in the 
experimental group on the 1st day was significantly different than on 
the 3rd and 5th days (p=0.001 and p<0.001).
The result from the histological examination results using the IHK 
caspase-3 from each group on days 1, 3, and 5 are presented in Figs. 2-4.
DISCUSSION
Several studies have proved that an injection of BP in the buccal mucosa, 
combined with orthodontic force, could inhibit the orthodontic tooth 
movement arising from the apoptosis of osteoclasts cells [18,19,21,24]. 
However, the injection may cause discomfort, pain, and a systemic 
effect. Thus, there is a need to develop a new type of BP in the form 
of a gel emulsion to overcome these effects [28]. BP consists of two 
families: Non-nitrogen-containing BP and nitrogen-containing BP. The 
newest generation of BP is ZOL, a nitrogen-containing heterocyclic 
imidazole BP, which has been shown to have potential as an inhibitor 
of bone resorption [11-18]. The gel form was chosen because its usage 
Fig. 1: Number of apoptotic osteoclast cells in experimental, 
control, and normal groups on the days 1, 3, and 5 with one-way 
ANOVA test. *p<0.05
Fig. 2: Histological view of alveolar bone from experimental, 
control, and normal groups on the day 1, stained with IHK 
caspase-3, ×20 magnification, bar 50 μm. The arrows showed 
osteoclast apoptosis (brown multinucleated giant cells). 
(a) Experimental group on the day 1, (b) control group on the 
day 1, (c) normal group on the day 1. The number of apoptotic 
osteoclast cells in figure a is higher than that in b or c
cba
Fig. 3: Histological view of alveolar bone from experimental, 
control, and normal groups on the day 3, stained with IHK 
caspase-3, ×20 magnification, bar 50 μm. The arrow shows 
osteoclast apoptosis (brown multinucleated giant cells). 
(a) Experimental group on the day 3, (b) control group on the 
day 3, (c) normal group on the day 3. The number of apoptotic 
osteoclast cells in figure a is almost same as that in b and c
cba
Table 1: Analysis of the number of apoptotic osteoclast cells in 
the experimental group on the days 1, 3, and 5




Post hoc bonferroni test. *p<0.05
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in oral medication is well-known. Therefore, it was expected that the 
topical application of ZOL in a gel emulsion would have the same effect 
as the BP injection. The use of the gel emulsion is very simple, and it 
can be applied to the oral mucosa without pain and is, therefore, more 
comfortable for the patients. VCO and CMC were the gel emulsions 
chosen for this study: CMC is known as a mucoadhesive polymer that is 
capable of attaching and penetrating oral mucosa. VCO is pure coconut 
oil, derived from fresh coconut flesh, consisting of medium chain 
saturated fatty acids such as lauric acid and capric acid, which are easily 
absorbed by the body [27]. Until now, there has been no ZOL BP in the 
form of a gel emulsion.
The ZOL BP dose used in this study was 40 µg, which is 3 times the 
dose used in an injection. The epithelial layer of rats’ oral mucosa is 
not different from the epithelial layer of human oral mucosa. However, 
the thickness of rats’ oral mucosa is less than that of the human, with 
about 40 and 140 µm thickness, respectively. A study using a PGE2 gel at 
a dosage of 25 µg PGE2 which was 3 times the dose of a PGE2 injection, 
was performed in Sprague-Dawley rats at 0, 2, and 4 h [29]. The results 
showed that a repeated gel application could penetrate the rats’ oral 
mucosa layer and increase the inflammatory cell count. The present 
study used 25 mg of Ge-ZOL, consisting of 40 µg ZOL, applied to the 
buccal mucosa lower right first molar of nine rats in the experimental 
group at hours 0, 4 and 8. Fig. 1 shows that topical application of gel 
ZOL had the effect of increasing osteoclast apoptosis. This means that 
Ge-ZOL penetrated deep into the oral mucosa layer to the alveolar bone.
In the present study, IHK Caspase-3 was used in the histological 
staining to count the number of apoptotic osteoclast cells. Osteoclast 
apoptosis was indicated by the brown cells that could be seen with 
the IHK caspase-3 staining (Figs. 2-4). IHK caspase-3 staining contains 
antibodies that detect and bind to antigen caspase-3 on osteoclast 
undergoing apoptosis [23]. An apoptotic osteoclast cell count was 
then performed using the Olympus IX73 research inverted microscope 
with 20x magnification. The number of apoptotic osteoclast cells on 
the 1st day shown in Fig. 2a is higher than that in Fig. 2b and c. The 
result shown in Fig. 2a-c is reflected in Fig. 1 and indicates that Ge-ZOL 
with VCO is capable of causing osteoclast cells apoptosis 24 h after the 
application of Ge-ZOL. The result of this study is in accordance with the 
study by Benford et al., which found that administration of ZOL to cell 
cultures was able to increase the number of apoptotic osteoclast cells 
after 24 h, using the biomarkers caspase-3 [23].
A post hoc Bonferroni test showed that the number of apoptotic 
osteoclast cells in the experimental group on the day 1 had a statistically 
significant difference when compared to the number of these cells 
on the days 3 and 5 (p=0.001 and p<0.001). However, the number of 
apoptotic osteoclast cells on the days 3 and 5 was not significantly 
different from each other (p=0.251) (Table 1). The number of apoptotic 
osteoclast cells in the control and normal groups was almost the same 
throughout, so the control group was validated by the normal groups. 
It can be concluded that Ge- with VCO alone is not capable of increasing 
the number of apoptotic osteoclast cells and that is the addition of ZOL 
that increases the apoptotic of the osteoclast. A cotton bud was used 
with a circular movement for 2 min to apply the gel in the control group. 
There may be some pressure applied during this twisting motion, but 
the pressure did not increase the osteoclast apoptosis (Fig. 1).
From this result, we can conclude that VCO is a good delivery system 
because it can deliver ZOL through the oral mucosa and increase the 
number of apoptotic osteoclast cells.
This study showed that a repeated application of Ge-ZOL with VCO to 
oral mucosa, at a dose of 40 µg, can increase the number of apoptotic 
osteoclast cells on the day 1. Therefore, Ge-ZOL has potential for use as 
a locally applied medicine to inhibit osteoclastic bone resorption. This 
present study is a pilot study; further research is needed to identify 
the effect of Ge-ZOL in orthodontic tooth movement. Moreover, further 
experiments are needed to explore the biologic, physical, and chemical 
stability of Ge-ZOL with VCO, the optimal dose of Ge-ZOL with VCO, and 
the best time for application time of Ge-ZOL with VCO.
CONCLUSIONS
It is concluded that a gel emulsion ZOL BP in VCO can penetrate into the 
alveolar bone of rats based on the increase in apoptosis of the osteoclast 
cells. The number of apoptotic osteoclast cells in the experimental 
groups on the day 1 was higher than on the day 3 or day 5.
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